679 related articles for article (PubMed ID: 26336870)
1. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
Jin L; He Y; Tang S; Huang S
J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8(1):57. PubMed ID: 27391317
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell apoptosis by epigenetic silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Xia R; Sun M; Xu TP; Yin L; Zhang EB; De W; Shu YQ
J Hematol Oncol; 2015 May; 8():50. PubMed ID: 25966845
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance.
Refai NS; Louka ML; Halim HY; Montasser I
J Gene Med; 2019 Sep; 21(9):e3112. PubMed ID: 31301261
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma.
Wen J; Xu J; Sun Q; Xing C; Yin W
Mol Med Rep; 2016 May; 13(5):4481-6. PubMed ID: 27035680
[TBL] [Abstract][Full Text] [Related]
10. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z
Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z
Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238
[TBL] [Abstract][Full Text] [Related]
14. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression.
Zhang EB; Yin DD; Sun M; Kong R; Liu XH; You LH; Han L; Xia R; Wang KM; Yang JS; De W; Shu YQ; Wang ZX
Cell Death Dis; 2014 May; 5(5):e1243. PubMed ID: 24853421
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Wei C; Wang H; Xu F; Liu Z; Jiang R
Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
17. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
Jiang H; Hu X; Zhang H; Li W
Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.
Yang F; Zhang L; Huo XS; Yuan JH; Xu D; Yuan SX; Zhu N; Zhou WP; Yang GS; Wang YZ; Shang JL; Gao CF; Zhang FR; Wang F; Sun SH
Hepatology; 2011 Nov; 54(5):1679-89. PubMed ID: 21769904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
